ArticleFrontiers in endocrinology2026
Case Report: Rare collision tumors: ACTH-secreting pituitary neuroendocrine tumor and pituicytoma - histopathological and ultrastructural analysis.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Collision tumors are rare conditions characterized by the coexistence of two histologically distinct neoplasms in the same region without histological admixture or an intermediate cell population zone. Our report represents one of the few studies on a collision tumor composed of an ACTH-secreting pituitary neuroendocrine tumor (PitNET) and a sellar pituicytoma. Here, we describe the clinical presentation, radiological findings, immunohistochemical/histopathological analysis, and ultrastructural examination of a 21-year-old woman with two different intracranial primary tumors at adjacent sites. Magnetic resonance imaging of the sellar region revealed a focal, 4 mm, nodular lesion in the left lateral recess that was hypointense on T2 and compatible with a micro-PitNET. Transnasal transsphenoidal resection was performed. Histopathological analysis revealed patterns consistent with a corticotroph PitNET, with diffuse cytoplasmic ACTH immunostaining and a Ki-67 index of 4%. Furthermore, the specimens included scattered adenohypophyseal and neural tissue. The latter was characterized by increased neoplastic proliferation consistent with a pituicytoma, confirmed by nuclear positivity for TTF-1 and a Ki-67 index of 3%. Ultrastructural analysis confirmed the coexistence of two morphologically distinct lesions. Postoperatively, the patient developed diabetes insipidus and remained in clinical and biochemical remission with no remaining tumor at nine months post-surgery. Pituitary collision tumors are sporadically reported and rare. Specifically, pituicytomas associated with pituitary hyperfunction are notably infrequent, and those linked to Cushing's disease are extremely uncommon. This case highlights the exceptional rarity of sellar collision tumors and underscores the importance of reporting such cases to improve recognition, refine diagnostic strategies, and expand current understanding of complex pituitary tumor biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.